Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Pollard

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
The Journal of Infection|March 29, 2024
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiologyN G Martin, S Defres, L Willis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestisChristina Dold, Laura Silva-Reyes, Young Chan Kim, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic settingN Stoesser, A Giess, E M Batty, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
High Altitude Medicine & Biology|October 30, 2001
Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001A J Pollard, S Niermeyer, P Barry, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
The Journal of Infection|March 29, 2024
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiologyN G Martin, S Defres, L Willis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestisChristina Dold, Laura Silva-Reyes, Young Chan Kim, et al.
Antimicrobial Agents and Chemotherapy|October 1, 2014
Genome sequencing of an extended series of NDM-producing Klebsiella pneumoniae isolates from neonatal infections in a Nepali hospital characterizes the extent of community- versus hospital-associated transmission in an endemic settingN Stoesser, A Giess, E M Batty, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
High Altitude Medicine & Biology|October 30, 2001
Children at high altitude: an international consensus statement by an ad hoc committee of the International Society for Mountain Medicine, March 12, 2001A J Pollard, S Niermeyer, P Barry, et al.
NPJ Vaccines|April 15, 2025
Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine developmentE Z Siegal, J M H Schoevers, J Terstappen, et al.
Pageof 11